Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
RAPP on Nasdaq
David Bredt - trading volume in the past year for Rapport Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
461K |
$4.41M |
$9.57 |
Apr 15, 2025 |
Direct |
|
|
| Stock Option (Right to Buy) |
100K |
|
|
Feb 3, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.